Please check your internet connection and try again.
# Walethmade bromide
## Overview
**Note:** There is no FDA-approved medication marketed under the name "Walethmade bromide." It is highly probable that this is a transcription error or an obscured trade name. If you are referring to **Ipratropium bromide** or **Tiotropium bromide**, please verify the spelling, as these are common therapeutic bromides. **Do not attempt to administer this substance until the identity is confirmed.**
## Primary Indications
Assuming potential confusion with cholinergic antagonists (e.g., Ipratropium): Bronchospasm associated with COPD or asthma; rhinorrhea.
## Adult Dosing
*If referring to Ipratropium MDI:* 2 inhalations (36 mcg) every 6 hours, as needed. Maximum: 12 inhalations in 24 hours.
## Pediatric Dosing
*If referring to Ipratropium MDI/Nebulizer:* Dosage varies significantly by age and weight. Consult local institutional protocols or PDR/Lexicomp for age-specific weight-based dosing.
## Dose Adjustments
*Renal/Hepatic:* Generally no dose adjustment required for inhaled anticholinergics; however, systemic exposure should be monitored in severe renal impairment.
## Contraindications
* Hypersensitivity to bromide, ipratropium, atropine, or derivatives.
* History of hypersensitivity to soy lecithin or related food products (in specific MDI formulations).
## Adverse Effects
* Common: Dry mouth, pharyngitis, headache, cough, nervousness.
* Serious: Paradoxical bronchospasm, urinary retention, narrow-angle glaucoma precipitation, tachycardia.
## Key Drug Interactions
* Additive anticholinergic effects with other agents (e.g., antihistamines, TCAs).
* Potential for reduced efficacy if used simultaneously with nebulized surfactants.
## Monitoring
* Monitor respiratory rate, auscultation of lung sounds, and oxygen saturation.
* Monitor for signs of urinary retention or ocular pain/blurred vision.
## Clinical Pearls
* **Verification Essential:** As "Walethmade bromide" is not a recognized drug entity, do not proceed with clinical use. Verify the intended medication name from the original prescription or the patient's medication list.
* **Administration:** Ensure patients understand proper MDI or nebulizer technique to maximize airway delivery and reduce systemic absorption.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug information is subject to change. Always verify current prescribing information, institutional protocols, and patient-specific factors with verified medical references (e.g., Lexicomp, Clinical Pharmacology) before prescribing or administering any medication.
